Table 2.
MBFR>2.0 | MBFR≤2.0 | p-value | |
---|---|---|---|
| |||
Stress Agent | 0.21 | ||
Adenosine | 3 (2.8) | 2 (2.8) | |
Dipyridamole | 105 (97.2) | 67 (94.4) | |
Regadenoson | 0 (0) | 2 (2.8) | |
Myocardial Blood Flow | |||
Total Stress Myocardial Blood Flow | 2.32 (2.03–2.62) | 1.47 (1.22–1.69) | <0.0001 |
Total Rest Myocardial Blood Flow | 0.94 (0.85–1.03) | 0.90 (0.82–1.0) | 0.08 |
Total Myocardial Flow Reserve | 2.60 (2.20–3.0) | 1.63 (1.35–1.80) | <0.0001 |
Resting Ejection Fraction | 60.1±7.4 | 57.3±10.4 | 0.06 |
Stress Ejection Fraction | 63.0±7.0 | 59.4±10.6 | 0.03 |
Any Ischemia | 6 (5.5) | 12 (16.9) | 0.02 |
<5% of myocardium | 4 (3.6) | 2 (2.8) | |
5–10% of myocardium | 1 (0.9) | 5 (7.0) | |
>10% of myocardium | 1 (0.9) | 5 (7.0) | |
Transient ischemic dilation | 0 (0) | 1 (1.4) | 0.21 |
Coronary Calcium | 0.01 | ||
No Coronary Calcium | 85 (80.2) | 40 (62.5) | |
Any Coronary Calcium | 21 (19.8) | 24 (37.5) | |
VECAC | |||
0 | 85 (80.2) | 40 (62.5) | 0.11 |
1–99 | 5 (4.7) | 8 (12.5) | |
10–99 | 7 (6.6) | 7 (10.9) | |
100–399 | 7 (6.6) | 6 (9.4) | |
400–999 | 2 (1.9) | 3 (4.7) |
Data presented as count (%) and median (interquartile range). VECAC=Visually estimated coronary artery calcium